{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260812579720/en/Definium-Therapeutics-Announces-Positive-Topline-Results-from-Phase-3-Voyage-Study-of-DT120-ODT-in-Generalized-Anxiety-Disorder", "message": "News view counter 877804 successfully enlarged"}